vs
Side-by-side financial comparison of MARKETWISE, INC. (MKTW) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.
MARKETWISE, INC. is the larger business by last-quarter revenue ($83.4M vs $83.1M, roughly 1.0× PROCEPT BioRobotics Corp). MARKETWISE, INC. runs the higher net margin — 2.3% vs -38.1%, a 40.4% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs -14.4%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs -12.5%).
MarketWise Inc. is a leading provider of investment research, financial market data, and wealth management education solutions. It serves both retail and institutional investors across North America, Europe, and the Asia-Pacific region, offering actionable market insights, portfolio analysis tools, and specialized multi-asset research.
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
MKTW vs PRCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $83.4M | $83.1M |
| Net Profit | $1.9M | $-31.6M |
| Gross Margin | 87.0% | 64.9% |
| Operating Margin | 15.8% | -4.1% |
| Net Margin | 2.3% | -38.1% |
| Revenue YoY | -14.4% | 20.2% |
| Net Profit YoY | -9.8% | -27.9% |
| EPS (diluted) | $0.79 | $-0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $83.1M | ||
| Q4 25 | $83.4M | $76.4M | ||
| Q3 25 | $81.3M | $83.3M | ||
| Q2 25 | $80.0M | $79.2M | ||
| Q1 25 | $83.5M | $69.2M | ||
| Q4 24 | $97.5M | $68.2M | ||
| Q3 24 | $97.2M | $58.4M | ||
| Q2 24 | $105.0M | $53.4M |
| Q1 26 | — | $-31.6M | ||
| Q4 25 | $1.9M | $-29.8M | ||
| Q3 25 | $1.5M | $-21.4M | ||
| Q2 25 | $1.3M | $-19.6M | ||
| Q1 25 | $890.0K | $-24.7M | ||
| Q4 24 | $2.1M | $-18.9M | ||
| Q3 24 | $1.7M | $-21.0M | ||
| Q2 24 | $1.5M | $-25.6M |
| Q1 26 | — | 64.9% | ||
| Q4 25 | 87.0% | 60.6% | ||
| Q3 25 | 87.0% | 64.8% | ||
| Q2 25 | 86.3% | 65.4% | ||
| Q1 25 | 85.7% | 63.9% | ||
| Q4 24 | 88.7% | 64.0% | ||
| Q3 24 | 86.7% | 63.2% | ||
| Q2 24 | 87.3% | 59.0% |
| Q1 26 | — | -4.1% | ||
| Q4 25 | 15.8% | -40.6% | ||
| Q3 25 | 21.9% | -27.8% | ||
| Q2 25 | 18.5% | -28.0% | ||
| Q1 25 | 20.1% | -39.7% | ||
| Q4 24 | 24.8% | -28.9% | ||
| Q3 24 | 22.5% | -38.4% | ||
| Q2 24 | 20.3% | -50.3% |
| Q1 26 | — | -38.1% | ||
| Q4 25 | 2.3% | -39.1% | ||
| Q3 25 | 1.9% | -25.7% | ||
| Q2 25 | 1.6% | -24.7% | ||
| Q1 25 | 1.1% | -35.8% | ||
| Q4 24 | 2.2% | -27.6% | ||
| Q3 24 | 1.8% | -35.9% | ||
| Q2 24 | 1.5% | -48.0% |
| Q1 26 | — | $-0.56 | ||
| Q4 25 | $0.79 | $-0.54 | ||
| Q3 25 | $0.58 | $-0.38 | ||
| Q2 25 | $0.53 | $-0.35 | ||
| Q1 25 | $0.41 | $-0.45 | ||
| Q4 24 | $1.06 | $-0.34 | ||
| Q3 24 | $0.87 | $-0.40 | ||
| Q2 24 | $0.80 | $-0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $70.1M | $245.6M |
| Total DebtLower is stronger | — | $51.7M |
| Stockholders' EquityBook value | $-11.7M | $347.7M |
| Total Assets | $218.4M | $487.1M |
| Debt / EquityLower = less leverage | — | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $245.6M | ||
| Q4 25 | $70.1M | $286.5M | ||
| Q3 25 | $50.5M | $294.3M | ||
| Q2 25 | $69.1M | $302.7M | ||
| Q1 25 | $79.2M | $316.2M | ||
| Q4 24 | $97.9M | $333.7M | ||
| Q3 24 | $94.1M | $196.8M | ||
| Q2 24 | $109.3M | $214.1M |
| Q1 26 | — | $51.7M | ||
| Q4 25 | — | $51.6M | ||
| Q3 25 | — | $51.6M | ||
| Q2 25 | — | $51.5M | ||
| Q1 25 | — | $51.5M | ||
| Q4 24 | — | $51.5M | ||
| Q3 24 | — | $51.4M | ||
| Q2 24 | — | $51.4M |
| Q1 26 | — | $347.7M | ||
| Q4 25 | $-11.7M | $365.9M | ||
| Q3 25 | $-14.5M | $380.3M | ||
| Q2 25 | $-15.8M | $385.8M | ||
| Q1 25 | $-15.8M | $389.2M | ||
| Q4 24 | $-12.5M | $402.2M | ||
| Q3 24 | $-19.5M | $241.2M | ||
| Q2 24 | $-23.7M | $251.8M |
| Q1 26 | — | $487.1M | ||
| Q4 25 | $218.4M | $508.1M | ||
| Q3 25 | $201.7M | $511.5M | ||
| Q2 25 | $211.8M | $513.1M | ||
| Q1 25 | $239.6M | $519.4M | ||
| Q4 24 | $259.5M | $534.0M | ||
| Q3 24 | $278.4M | $374.1M | ||
| Q2 24 | $315.3M | $374.4M |
| Q1 26 | — | 0.15× | ||
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 0.14× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $46.0M | — |
| Free Cash FlowOCF − Capex | $45.6M | — |
| FCF MarginFCF / Revenue | 54.6% | — |
| Capex IntensityCapex / Revenue | 0.5% | — |
| Cash ConversionOCF / Net Profit | 23.84× | — |
| TTM Free Cash FlowTrailing 4 quarters | $67.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $46.0M | $-10.3M | ||
| Q3 25 | $2.2M | $-6.6M | ||
| Q2 25 | $17.8M | $-15.0M | ||
| Q1 25 | $1.7M | $-17.0M | ||
| Q4 24 | $-22.1M | $-32.4M | ||
| Q3 24 | $-5.8M | $-18.8M | ||
| Q2 24 | $-3.8M | $-15.7M |
| Q1 26 | — | — | ||
| Q4 25 | $45.6M | $-12.2M | ||
| Q3 25 | $2.2M | $-9.5M | ||
| Q2 25 | $17.7M | $-17.8M | ||
| Q1 25 | $1.7M | $-18.8M | ||
| Q4 24 | $-22.3M | $-33.6M | ||
| Q3 24 | $-5.9M | $-19.0M | ||
| Q2 24 | $-3.8M | $-16.8M |
| Q1 26 | — | — | ||
| Q4 25 | 54.6% | -15.9% | ||
| Q3 25 | 2.7% | -11.4% | ||
| Q2 25 | 22.2% | -22.5% | ||
| Q1 25 | 2.0% | -27.2% | ||
| Q4 24 | -22.9% | -49.2% | ||
| Q3 24 | -6.0% | -32.6% | ||
| Q2 24 | -3.6% | -31.4% |
| Q1 26 | — | — | ||
| Q4 25 | 0.5% | 2.4% | ||
| Q3 25 | 0.0% | 3.4% | ||
| Q2 25 | 0.1% | 3.5% | ||
| Q1 25 | 0.1% | 2.7% | ||
| Q4 24 | 0.1% | 1.7% | ||
| Q3 24 | 0.0% | 0.4% | ||
| Q2 24 | 0.0% | 2.0% |
| Q1 26 | — | — | ||
| Q4 25 | 23.84× | — | ||
| Q3 25 | 1.44× | — | ||
| Q2 25 | 13.76× | — | ||
| Q1 25 | 1.95× | — | ||
| Q4 24 | -10.36× | — | ||
| Q3 24 | -3.39× | — | ||
| Q2 24 | -2.46× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MKTW
Segment breakdown not available.
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
